Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Fulgent Genetics stock

Own Fulgent Genetics stock in just a few minutes.

Posted

Fact checked

Fulgent Genetics, Inc is a diagnostics & research business based in the US. Fulgent Genetics shares (FLGT) are listed on the NASDAQ and all prices are listed in US Dollars. Fulgent Genetics employs 473 staff and has a trailing 12-month revenue of around USD$135.1 million.

How to buy shares in Fulgent Genetics

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Fulgent Genetics. Find the stock by name or ticker symbol: FLGT. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Fulgent Genetics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Fulgent Genetics, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Fulgent Genetics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Fulgent Genetics share price

Use our graph to track the performance of FLGT stocks over time.

Fulgent Genetics shares at a glance

Information last updated 2021-02-23.
52-week rangeUSD$6.7 - USD$189.89
50-day moving average USD$104.0388
200-day moving average USD$56.1039
Wall St. target priceUSD$85
PE ratio 50.7944
Dividend yield N/A (0%)
Earnings per share (TTM) USD$2.14

Buy Fulgent Genetics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Tastyworks
$0
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TradeStation
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Fulgent Genetics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Fulgent Genetics under- or over-valued?

Valuing Fulgent Genetics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fulgent Genetics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Fulgent Genetics's P/E ratio

Fulgent Genetics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 51x. In other words, Fulgent Genetics shares trade at around 51x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Fulgent Genetics's PEG ratio

Fulgent Genetics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.32. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Fulgent Genetics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Fulgent Genetics's EBITDA

Fulgent Genetics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$66.2 million.

The EBITDA is a measure of a Fulgent Genetics's overall financial performance and is widely used to measure a its profitability.

Fulgent Genetics financials

Revenue TTM USD$135.1 million
Operating margin TTM 47.25%
Gross profit TTM USD$18.4 million
Return on assets TTM 25.87%
Return on equity TTM 39.51%
Profit margin 35.31%
Book value $8.021
Market capitalisation USD$2.6 billion

TTM: trailing 12 months

Shorting Fulgent Genetics shares

There are currently 4.2 million Fulgent Genetics shares held short by investors – that's known as Fulgent Genetics's "short interest". This figure is 0.8% up from 4.1 million last month.

There are a few different ways that this level of interest in shorting Fulgent Genetics shares can be evaluated.

Fulgent Genetics's "short interest ratio" (SIR)

Fulgent Genetics's "short interest ratio" (SIR) is the quantity of Fulgent Genetics shares currently shorted divided by the average quantity of Fulgent Genetics shares traded daily (recently around 2.5 million). Fulgent Genetics's SIR currently stands at 1.68. In other words for every 100,000 Fulgent Genetics shares traded daily on the market, roughly 1680 shares are currently held short.

However Fulgent Genetics's short interest can also be evaluated against the total number of Fulgent Genetics shares, or, against the total number of tradable Fulgent Genetics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Fulgent Genetics's short interest could be expressed as 0.17% of the outstanding shares (for every 100,000 Fulgent Genetics shares in existence, roughly 170 shares are currently held short) or 0.2898% of the tradable shares (for every 100,000 tradable Fulgent Genetics shares, roughly 290 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Fulgent Genetics.

Find out more about how you can short Fulgent Genetics stock.

Fulgent Genetics share dividends

We're not expecting Fulgent Genetics to pay a dividend over the next 12 months.

Fulgent Genetics share price volatility

Over the last 12 months, Fulgent Genetics's shares have ranged in value from as little as $6.7 up to $189.89. A popular way to gauge a stock's volatility is its "beta".

FLGT.US volatility(beta: 1.69)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fulgent Genetics's is 1.6935. This would suggest that Fulgent Genetics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Fulgent Genetics overview

Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. Fulgent Genetics has collaboration with PWNHealth to provide at-home Covid-19 test capabilities. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site